This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03711890.
Locations matching your search criteria
United States
Ohio
Columbus
Ohio State University Comprehensive Cancer CenterStatus: Active
Contact: Mary Elizabeth Dillhoff
Phone: 614-293-7171
PRIMARY OBJECTIVES:
I. To evaluate the using of optical coherence tomography (OCT) to diagnose pancreatic cancer arising in the setting of intraductal papillary mucinous neoplasms (IPMN) using the resected pancreatic specimen.
II. To correlate OCT images diagnosis with histologic findings in the human pancreatic duct.
OUTLINE:
Participants undergo resection. Resected tissues are analyzed via ultra-high resolution OCT.
Trial PhaseNo phase specified
Trial Typediagnostic
Lead OrganizationOhio State University Comprehensive Cancer Center
Principal InvestigatorMary Elizabeth Dillhoff
